Basics Bicara Therapeutics Inc. Common Stock IPO Date: September 13, 2024 Sector: Healthcare Industry: Biotech Market Cap: $557.91M Activated in VL: True Average Daily Range Avg Daily Range: $0.62 | 4.06% Avg Daily Range (30 D): $0.36 | 3.52% Avg Daily Range (90 D): $0.51 | 4.34% Institutional Daily Volume Avg Daily Volume: .49M Avg Daily Volume (30 D): .42M Avg Daily Volume (90 D): .64M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 225 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $1.39M Avg Inst. Trade (90 D): $1.13M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.7M Avg Closing Trade (30 D): $1.56M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 125.86K     News Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A May 22, 2025 @ 9:00 PM Bicara Therapeutics Announces Publication of an Ab... Source: N/A Apr 23, 2025 @ 2:00 PM Bicara Therapeutics to Present Updated Data from O... Source: N/A Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: Globe Newswire Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $14.21 $-.68 $7.22 Diluted EPS $14.21 $-.68 $7.22 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -92.33M $ -36.85M $ -20.96M Operating Income / Loss $ -108.8M $ -41.79M $ -26.64M Cost of Revenue $ $ $ Net Cash Flow $ 273.66M $ M $ -31.05M PE Ratio 0.83